Embecta Corporation ( (EMBC) ) has issued an announcement.
Embecta announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.
Hosted on MSN1dOpinion
New Strong Buy Stocks for December 2ndList today: Embecta Corp. EMBC: This medical device company has seen the Zacks Consensus Estimate for its current year ...
Dynamic Technology Lab Private Ltd lessened its stake in Embecta Corp. (NASDAQ:EMBC – Free Report) by 6.4% during the 3rd ...
Kurdikar, CEO of Embecta (EMBC) said, “As our stand-up work nears completion and following an in-depth review of our ...
CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the ...
PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference ...
(RTTNews) - Diabetes management company Embecta Corp. (EMBC), which was spun-off from medical technology company Becton, Dickinson and Co. (BDX), announced Tuesday that net income for the fourth ...
BofA raised the firm’s price target on Embecta (EMBC) to $20 from $17 and keeps an Underperform rating on the shares after the company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback